Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwee Yong

Showing results (61-70 of 188) with videos related to

Pageof 19
Sort By:
Journal of Clinical Epidemiology|April 15, 2020
The adapted Zelen was a feasible design to trial exercise in myeloma survivorsJoanne Land, Orla McCourt, Malgorzata Heinrich, et al.
Plos One|September 7, 2012
Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myelomaClive Henry Buckle, Evy De Leenheer, Michelle Anne Lawson, et al.
Cytometry. Part B, Clinical Cytometry|November 12, 2022
Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real-world practiceAnnabel McMillan, Thien-An Tran, Daria Galas-Filipowicz, et al.
British Journal of Haematology|May 20, 2026
Recognising disease progression in MGUS and smouldering myeloma: Biomarkers, symptom monitoring and imagingAidan Haslam, Gulnaz Iqbal, Mark Drayson, et al.
European Journal of Haematology|May 22, 2019
Understanding mortality in multiple myeloma: Findings of a European retrospective chart reviewMohamad Mohty, Michele Cavo, Leah Fink, et al.
Future Oncology (London, England)|September 15, 2021
Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM studyPaul G Richardson, Simon J Harrison, Sara Bringhen, et al.
Journal of Medical Economics|December 27, 2017
Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and ItalySebastian Gonzalez-McQuire, Kwee Yong, Henri Leleu, et al.
International Journal of Antimicrobial Agents|July 24, 2014
Expansive spread of IncI1 plasmids carrying blaCMY-2 amongst Escherichia coliHanna E Sidjabat, Kwee Yong Seah, Lyndall Coleman, et al.
Blood|October 25, 2003
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responsesKarl S Peggs, Kirsty Thomson, Daniel P Hart, et al.
British Journal of Haematology|January 21, 2017
Guidelines for screening and management of late and long-term consequences of myeloma and its treatmentJohn A Snowden, Diana M Greenfield, Jennifer M Bird, et al.
Pageof 19

Showing results (61-70 of 188) with videos related to

Sort By:
Pageof 19
Journal of Clinical Epidemiology|April 15, 2020
The adapted Zelen was a feasible design to trial exercise in myeloma survivorsJoanne Land, Orla McCourt, Malgorzata Heinrich, et al.
Plos One|September 7, 2012
Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myelomaClive Henry Buckle, Evy De Leenheer, Michelle Anne Lawson, et al.
Cytometry. Part B, Clinical Cytometry|November 12, 2022
Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real-world practiceAnnabel McMillan, Thien-An Tran, Daria Galas-Filipowicz, et al.
British Journal of Haematology|May 20, 2026
Recognising disease progression in MGUS and smouldering myeloma: Biomarkers, symptom monitoring and imagingAidan Haslam, Gulnaz Iqbal, Mark Drayson, et al.
European Journal of Haematology|May 22, 2019
Understanding mortality in multiple myeloma: Findings of a European retrospective chart reviewMohamad Mohty, Michele Cavo, Leah Fink, et al.
Future Oncology (London, England)|September 15, 2021
Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM studyPaul G Richardson, Simon J Harrison, Sara Bringhen, et al.
Journal of Medical Economics|December 27, 2017
Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and ItalySebastian Gonzalez-McQuire, Kwee Yong, Henri Leleu, et al.
International Journal of Antimicrobial Agents|July 24, 2014
Expansive spread of IncI1 plasmids carrying blaCMY-2 amongst Escherichia coliHanna E Sidjabat, Kwee Yong Seah, Lyndall Coleman, et al.
Blood|October 25, 2003
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responsesKarl S Peggs, Kirsty Thomson, Daniel P Hart, et al.
British Journal of Haematology|January 21, 2017
Guidelines for screening and management of late and long-term consequences of myeloma and its treatmentJohn A Snowden, Diana M Greenfield, Jennifer M Bird, et al.
Pageof 19